Treatment of breakthrough and prevention of refractory chemotherapy‐induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update-Reference-Cited by-同舟云学术

Treatment of breakthrough and prevention of refractory chemotherapy‐induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update

Published:2023-05-13 Issue:8 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Patel Priya¹²,Robinson Paula D.¹,Phillips Robert³,Baggott Christina⁴,Devine Katie⁵^ORCID,Gibson Paul¹⁶,Guilcher Gregory M. T.⁷⁸,Holdsworth Mark T.⁹,Neumann Eloise¹⁰,Orsey Andrea D.¹¹¹²,Spinelli Daniela¹³,Thackray Jennifer¹⁴^ORCID,van de Wetering Marianne¹⁵,Cabral Sandra¹,Sung Lillian¹⁶¹⁷,Dupuis L. Lee²¹⁷¹⁸^ORCID

Affiliation:

1. Pediatric Oncology Group of Ontario Toronto Ontario Canada

2. Department of Pharmacy The Hospital for Sick Children Toronto Ontario Canada

3. Department of Haematology and Oncology NHS Trust Leeds Teaching Hospital Leeds UK

4. Cancer Clinical Trials Office Stanford Cancer Institute Palo Alto California USA

5. Rutgers Cancer Institute of New Jersey New Brunswick New Jersey USA

6. Division of Haematology/Oncology McMaster Children's Hospital Hamilton Ontario Canada

7. Section of Paediatric Oncology and Blood and Marrow Transplant Alberta Children's Hospital Calgary Alberta Canada

8. Departments of Oncology and Paediatrics University of Calgary Cumming School of Medicine Calgary Alberta Canada

9. College of Pharmacy University of New Mexico Albuquerque New Mexico USA

10. Birmingham Women's and Children's Hospital Birmingham UK

11. Division of Pediatric Hematology/Oncology Connecticut Children's Medical Center Hartford Connecticut USA

12. Department of Pediatrics University of Connecticut School of Medicine Farmington Connecticut USA

13. Patient representative

14. Department of Pharmacy Memorial Sloan Kettering Cancer Center New York New York USA

15. Princess Maxima Center for Pediatric Oncology Utrecht Netherlands

16. Department of Paediatrics Division of Haematology/Oncology The Hospital for Sick Children Toronto Ontario Canada

17. Child Health Evaluative Sciences Research Institute The Hospital for Sick Children Toronto Ontario Canada

18. Leslie Dan Faculty of Pharmacy University of Toronto Toronto Ontario Canada

Abstract

AbstractThis clinical practice guideline update provides recommendations for treating breakthrough chemotherapy‐induced nausea and vomiting (CINV) and preventing refractory CINV in pediatric patients. Two systematic reviews of randomized controlled trials in adult and pediatric patients informed the recommendations. In patients with breakthrough CINV, escalation of antiemetic agents to those recommended for chemotherapy of the next higher level of emetogenic risk is strongly recommended. A similar recommendation to escalate therapy is made to prevent refractory CINV in patients who did not experience complete breakthrough CINV control and are receiving minimally or low emetogenic chemotherapy. A strong recommendation to use antiemetic agents that controlled breakthrough CINV for the prevention of refractory CINV is also made.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30395

Reference23 articles.

1. Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline

2. Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer

3. Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline

4. Prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update

5. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility and face validity of two patient reported outcome measures for nausea: Preferences of children with cancer;Journal of Pediatric Nursing;2024-09

2. Effects of technology-based interventions on chemotherapy-induced nausea, vomiting, and quality of life in pediatric patients: A systematic review and meta-analysis;Journal of Pediatric Nursing;2024-09

3. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score–weighted, retrospective assessment;Supportive Care in Cancer;2024-07-25

4. Nausées et vomissements chimio-induits en oncohématologie pédiatrique : actualisation 2023 des recommandations du comité soins de support de la SFCE;Bulletin du Cancer;2024-06

5. Efficacy of vitamin B1 in alleviating chemotherapy-induced nausea and vomiting;2024-04-25